Forest Phase III For Constipation-Predominant IBS To Begin In Late 2001
Forest will start Phase III trials for dexgloxiglumide in constipation-predominant irritable bowel syndrome before year-end.
Forest will start Phase III trials for dexgloxiglumide in constipation-predominant irritable bowel syndrome before year-end.